Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks

Abnormal aggregation of tau is the pathological hallmark of tauopathies including frontotemporal dementia (FTD). We have generated tau-transgenic mice that express the aggregation-prone P301S human tau (line 66). These mice present with early-onset, high tau load in brain and FTD-like behavioural de...

Full description

Bibliographic Details
Main Authors: Karima Schwab, Valeria Melis, Charles R. Harrington, Claude M. Wischik, Mandy Magbagbeolu, Franz Theuring, Gernot Riedel
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/8/2162
_version_ 1797524327647674368
author Karima Schwab
Valeria Melis
Charles R. Harrington
Claude M. Wischik
Mandy Magbagbeolu
Franz Theuring
Gernot Riedel
author_facet Karima Schwab
Valeria Melis
Charles R. Harrington
Claude M. Wischik
Mandy Magbagbeolu
Franz Theuring
Gernot Riedel
author_sort Karima Schwab
collection DOAJ
description Abnormal aggregation of tau is the pathological hallmark of tauopathies including frontotemporal dementia (FTD). We have generated tau-transgenic mice that express the aggregation-prone P301S human tau (line 66). These mice present with early-onset, high tau load in brain and FTD-like behavioural deficiencies. Several of these behavioural phenotypes and tau pathology are reversed by treatment with hydromethylthionine but key pathways underlying these corrections remain elusive. In two proteomic experiments, line 66 mice were compared with wild-type mice and then vehicle and hydromethylthionine treatments of line 66 mice were compared. The brain proteome was investigated using two-dimensional electrophoresis and mass spectrometry to identify protein networks and pathways that were altered due to tau overexpression or modified by hydromethylthionine treatment. Overexpression of mutant tau induced metabolic/mitochondrial dysfunction, changes in synaptic transmission and in stress responses, and these functions were recovered by hydromethylthionine. Other pathways, such as NRF2, oxidative phosphorylation and protein ubiquitination were activated by hydromethylthionine, presumably independent of its function as a tau aggregation inhibitor. Our results suggest that hydromethylthionine recovers cellular activity in both a tau-dependent and a tau-independent fashion that could lead to a wide-spread improvement of homeostatic function in the FTD brain.
first_indexed 2024-03-10T08:54:47Z
format Article
id doaj.art-b2500fa0bdfa475ebc7bdc4d30a9d076
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T08:54:47Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-b2500fa0bdfa475ebc7bdc4d30a9d0762023-11-22T07:12:37ZengMDPI AGCells2073-44092021-08-01108216210.3390/cells10082162Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent NetworksKarima Schwab0Valeria Melis1Charles R. Harrington2Claude M. Wischik3Mandy Magbagbeolu4Franz Theuring5Gernot Riedel6School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UKSchool of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UKSchool of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UKSchool of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UKCharité—Universitätsmedizin Berlin, Hessische Str. 3-4, 10115 Berlin, GermanyCharité—Universitätsmedizin Berlin, Hessische Str. 3-4, 10115 Berlin, GermanySchool of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UKAbnormal aggregation of tau is the pathological hallmark of tauopathies including frontotemporal dementia (FTD). We have generated tau-transgenic mice that express the aggregation-prone P301S human tau (line 66). These mice present with early-onset, high tau load in brain and FTD-like behavioural deficiencies. Several of these behavioural phenotypes and tau pathology are reversed by treatment with hydromethylthionine but key pathways underlying these corrections remain elusive. In two proteomic experiments, line 66 mice were compared with wild-type mice and then vehicle and hydromethylthionine treatments of line 66 mice were compared. The brain proteome was investigated using two-dimensional electrophoresis and mass spectrometry to identify protein networks and pathways that were altered due to tau overexpression or modified by hydromethylthionine treatment. Overexpression of mutant tau induced metabolic/mitochondrial dysfunction, changes in synaptic transmission and in stress responses, and these functions were recovered by hydromethylthionine. Other pathways, such as NRF2, oxidative phosphorylation and protein ubiquitination were activated by hydromethylthionine, presumably independent of its function as a tau aggregation inhibitor. Our results suggest that hydromethylthionine recovers cellular activity in both a tau-dependent and a tau-independent fashion that could lead to a wide-spread improvement of homeostatic function in the FTD brain.https://www.mdpi.com/2073-4409/10/8/2162mouse modeltau proteinfrontotemporal dementiaproteomicshydromethylthionineLMTM
spellingShingle Karima Schwab
Valeria Melis
Charles R. Harrington
Claude M. Wischik
Mandy Magbagbeolu
Franz Theuring
Gernot Riedel
Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks
Cells
mouse model
tau protein
frontotemporal dementia
proteomics
hydromethylthionine
LMTM
title Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks
title_full Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks
title_fullStr Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks
title_full_unstemmed Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks
title_short Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks
title_sort proteomic analysis of hydromethylthionine in the line 66 model of frontotemporal dementia demonstrates actions on tau dependent and tau independent networks
topic mouse model
tau protein
frontotemporal dementia
proteomics
hydromethylthionine
LMTM
url https://www.mdpi.com/2073-4409/10/8/2162
work_keys_str_mv AT karimaschwab proteomicanalysisofhydromethylthionineintheline66modeloffrontotemporaldementiademonstratesactionsontaudependentandtauindependentnetworks
AT valeriamelis proteomicanalysisofhydromethylthionineintheline66modeloffrontotemporaldementiademonstratesactionsontaudependentandtauindependentnetworks
AT charlesrharrington proteomicanalysisofhydromethylthionineintheline66modeloffrontotemporaldementiademonstratesactionsontaudependentandtauindependentnetworks
AT claudemwischik proteomicanalysisofhydromethylthionineintheline66modeloffrontotemporaldementiademonstratesactionsontaudependentandtauindependentnetworks
AT mandymagbagbeolu proteomicanalysisofhydromethylthionineintheline66modeloffrontotemporaldementiademonstratesactionsontaudependentandtauindependentnetworks
AT franztheuring proteomicanalysisofhydromethylthionineintheline66modeloffrontotemporaldementiademonstratesactionsontaudependentandtauindependentnetworks
AT gernotriedel proteomicanalysisofhydromethylthionineintheline66modeloffrontotemporaldementiademonstratesactionsontaudependentandtauindependentnetworks